<DOC>
	<DOCNO>NCT01308060</DOCNO>
	<brief_summary>This double-blind study two part subject ( population ) : Part A : initial treatment CL ( placebo-controlled ) : - To assess efficacy , safety duration effect Azzalure® compare placebo improvement moderate severe Lateral Canthal Lines . - To assess subject ' level satisfaction appearance Lateral Canthal Lines compare placebo . Part B : repeat treatment CL without GL ( active treatment , 1 year ) : - To assess safety Azzalure® follow repeat administration improvement moderate severe Lateral Canthal Lines . - To assess safety Azzalure® use concomitantly improvement moderate severe Lateral Canthal Lines Glabellar Lines . - To assess subject ' level satisfaction appearance Lateral Canthal Lines .</brief_summary>
	<brief_title>A Multi-Center Study Of CD07743 Improvement Lateral Canthal Lines ( CROW 'S FEET )</brief_title>
	<detailed_description />
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Male female subject , 18 65 year age ( Screening visit ) , Moderate severe ( grade 2 3 , Hund 2006 ) Lateral Canthal Lines `` maximum smile '' determine investigator screen baseline Mild severe ( grade 1 , 2 3 , Hund 2006 ) Lateral Canthal Lines `` rest '' determine investigator screen baseline The subject female childbearing potential negative urine pregnancy test ( UPT ) screen baseline Subjects satisfy appearance screen baseline The subject willing able comply requirement protocol agree adhere visit schedule , concomitant therapy prohibition must compliant study instruction . The subject agree participate study , verify date sign approve write Informed Consent Form ( ICF ) Photography Consent Form ( PCF ) ( select site applicable ) enrolment visit study procedure screen Any prior surgery affect orbicularis oculi muscle , prior blepharoplasty brow lift , prior cosmetic procedure scar may interfere evaluation investigator . Previous insertion permanent , semipermanent biodegradable material periorbital region facial treatment augmentation material ( e.g . silicon injection , collagen type implant , hyaluronic acid , lactic acid , etc . ) within 12 month prior screen . Any prior treatment botulinum toxin ( serotype ) Previous treatment laser skin resurface ( e.g . CO2laser ) treatment deep chemical peel esthetic dermatologic treatment procedure area face within 12 month prior screen . Any planned facial cosmetic surgery procedure study period . Presence bleed disorder Pregnant lactate woman woman plan pregnancy study . Known hypersensitivity test material related compound .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Canthal line</keyword>
</DOC>